We are pleased to announce the addition of two distinguished research groups to AGORA, with the full support of the AGORA Scientific Committee and Coordinating Body:
Professor Sébastien Waszak’s Group, EPFL
Professor Waszak is a leading figure in computational genomics and precision oncology. His group’s cutting-edge research harnesses computational methods and data-driven approaches to unlock new insights into the development and progression of pediatric gliomas. His work is set to advance diagnostics and therapeutic decision-making with real-time molecular information, further strengthening AGORA’s expertise in precision oncology.
Professor Andreas Hottinger’s Group, CHUV
Professor Hottinger is a renowned expert in neuro-oncology, with a focus on developing new treatment strategies against brain cancers. His group’s move to AGORA is closely linked with the Lundin Family Brain Cancer Research Centre. The aim of this centre is to foster strong research collaborations between the various clinical specialists involved in the management of patients with brain cancer and basic and translational laboratories. Their innovative and integrative approach is expected to have a profound impact on brain cancer treatment including on the development of novel immunotherapies. The Lundin Family Brain Cancer Research Centre already has ongoing collaborations with several teams from the AGORA, including the teams of Profs J. Joyce, D. Hanahan and D. Migliorini.
Image: Sébastien Waszak
Laboratory of Computational Neuro-Oncology, Tenure Track Assistant Professor, School of Life Sciences, École Polytechnique Fédérale de Lausanne; Associate Adjunct Professor, Department of Neurology, University of California, San Francisco
Image: Andreas Hottinger
Associate Professor, MD-PhD, Departments of oncology & Clinical Neurosciences, Director of the Lundin Family Brain Tumor Center, Director of the clinical “Centre des Tumeurs du Cerveau & de la moëlle épinière”, Lausanne University Hospital
Both Professors Waszak and Hottinger are internationally recognized for their pioneering research, and we are honored to have them join AGORA. Their presence will enrich our collaborative environment and create new opportunities for cross-disciplinary research and innovation.
